Rational Design of New Dihydrobenzooxophosphole-Based Lewis Base Organocatalysts

Bo Qu; Lalith P. Samankumara; Anjan Saha; Mac G. Schumer; Zhengxu S. Han; Nizar Haddad; Carl A. Busacca; Nathan K. Yee; Marisa C. Kozlowski; Jinghua J. Song; Chris H. Senanayake

doi:10.1055/s-0039-1690851

Synlett, Inhaltsverzeichnis

Synlett 2020; 31(06): 587-591
DOI: 10.1055/s-0039-1690851

cluster

Rational Design of New Dihydrobenzooxophosphole-Based Lewis Base Organocatalysts

Bo Qu ∗

^aChemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, USA

,

Lalith P. Samankumara

^aChemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, USA

,

Anjan Saha

^aChemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, USA

,

Mac G. Schumer

^bDepartment of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA

,

Zhengxu S. Han

^aChemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, USA

,

Nizar Haddad

^aChemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, USA

,

Carl A. Busacca

^aChemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, USA

,

Nathan K. Yee

^aChemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, USA

,

Marisa C. Kozlowski

^bDepartment of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA

,

Jinghua J. Song

^aChemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, USA

,

Chris H. Senanayake

^aChemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, USA

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Published as part of the ISySyCat2019 Special Issue

Abstract

A series of new dihydrobenzooxophosphole-based Lewis base organocatalysts were designed and synthesized. They are shown to be effective in trichlorosilane-mediated stereoselective conjugate reductions of C=C bonds. DFT calculations reveal that the strong hydrogen bonds between the amide linker and the chloride on silicon in the transition state contribute to the high reactivity of the catalyst.

Key words

chiral Lewis base - organocatalyst - enone reduction - hydrogen bonds

Volltext

Referenzen

References
1 Current address: TCG Lifesciences Private Limited, 737 North 5th Street, Richmond, Virginia 23219, US.

2a Denmark SE, Stavenger RA. Acc. Chem. Res. 2000; 33: 432
2b Guizzetti S, Benaglia M. Eur. J. Org. Chem. 2010; 5529

3a Shimoda Y, Kubo T, Sugiura M, Kotani S, Nakajima M. Angew. Chem. Int. Ed. 2013; 52: 3461
3b Aoki S, Kotani S, Sugiura M, Nakajima M. Chem. Commun. 2012; 48: 5524

4a Han ZS, Zhang L, Xu Y, Sieber JD, Marsini MA, Li Z, Reeves JT, Kandrick KR, Patel ND, Desrosiers J.-N, Qu B, Chen A, Rudzinski DM, Samankumara LP, Ma S, Grinberg N, Roschangar F, Yee NK, Wang G, Song JJ, Senanayake CH. Angew. Chem. Int. Ed. 2015; 54: 5474
4b Sugiura M, Sato N, Kotani S, Nakajima M. Chem. Commun. 2008; 4309

5 Li Z, Shi Y. Org. Lett. 2015; 17: 5752
6 Ogasawara M, Kotani S, Nakajima H, Furusho H, Miyasaka M, Shimoda Y, Wu W.-Y, Sugiura M, Takahashi T, Nakajima M. Angew. Chem. Int. Ed. 2013; 52: 13798
7 Kotani S, Hashimoto S, Nakajima M. Tetrahedron 2007; 63: 3122

8a Chong E, Qu B, Zhang Y, Cannone ZP, Leung JC, Tcyrulnikov S, Nguyen KD, Haddad N, Biswas S, Hou X, Kaczanowska K, Chwalba M, Tracz A, Czarnocki S, Song JJ, Kozlowski MC, Senanayake CH. Chem. Sci. 2019; 10: 4339
8b Tang W, Qu B, Capacci AG, Rodriguez S, Wei X, Haddad N, Narayanan B, Ma S, Grinberg N, Yee NK, Krishnamurthy D, Senanayake CH. Org. Lett. 2010; 12: 176

9a Sui-Seng C, Freutel F, Lough AJ, Morris RH. Angew. Chem. Int. Ed. 2008; 47: 940
9b Gao JX, Ikariya T, Noyori R. Organometallics 1996; 15: 1087

10a Li Y.-Y, Yu S.-L, Shen W.-Y, Gao J.-X. Acc. Chem. Res. 2015; 48: 2587
10b Trost BM. Tetrahedron 2015; 71: 5708
10c Trost BM, Van Vranken DL. Angew. Chem. Int. Ed. 1992; 21: 228

11 Qu B, Samankumara LP, Ma S, Fandrick KR, Desrosiers J.-N, Rodriguez S, Li Z, Haddad N, Han ZS, McKellop K, Pennino S, Grinberg N, Connella NC, Song JJ, Senanayake CH. Angew. Chem. Int. Ed. 2014; 53: 14428
12 General procedure for catalyst preparation: To a solution of carboxylic acid phosphine oxide (5.0 g, 17.6 mmol, 2.2 equiv), diamine (8.0 mmol, 1 equiv) and triethylamine (32.0 mmol, 4 equiv) in acetonitrile at room temperature was added propylphosphonic anhydride (T₃P) solution in DMF (16.0 mmol, 2 equiv) in portions over 3 h. The reaction was stopped after complete consumption of the carboxylic acid. The mixture was then treated with 50% aqueous NaOH (10 mL) and stirred at 35 °C for 3 h. The suspension was diluted with water and the resulting clear solution was extracted three times with EtOAc. The combined organic layer was washed with brine, dried with MgSO₄ and concentrated, and the crude mixture was purified by chromatography on silica (100% EtOAc to 10% MeOH/EtOAc) to obtain a white solid after drying.(2R,2′R,3S,3′S)-N,N′-((1R,2R)-cyclohexane-1,2-diyl)bis(3-(tert-butyl)-4-methoxy-2H-benzo[d][1,3]oxaphosphole-2-carboxamide 3-oxide) (3a): Yield: 3.67 g (71%). ¹H NMR (500 MHz, CDCl₃): δ = 7.46 (t, J = 8.23 Hz, 2 H), 6.80 (br d, J = 6.70 Hz, 2 H), 6.71 (dd, J = 8.3, 2.8 Hz, 2 H), 6.54 (dd, J = 8.2, 4.4 Hz, 2 H), 4.93 (s, 2 H), 3.88 (s, 6 H), 3.80 (br s, 2 H), 2.11 (br d, J = 7.3 Hz, 2 H), 1.65 (br s, 2 H), 1.37 (d, J = 17.0 Hz, 18 H), 1.25–1.23 (m, 4 H). ¹³C NMR (125 MHz, CDCl₃): δ = 165.2 (d, J = 2.7 Hz), 164.5 (d, J = 14.2 Hz), 161.1 (d, J = 2.4 Hz), 136.9 (d, J = 0.87 Hz), 106.6 (d, J = 5.3 Hz), 104.1 (d, J = 5.7 Hz), 102.70 (d, J = 90.8 Hz), 75.4 (d, J = 48.4 Hz), 55.6, 53.7, 34.07 (d, J = 74.5 Hz), 32.4, 25.1 (d, J = 0.96 Hz), 24.5. ³¹P NMR (202 MHz, CDCl₃): δ = 62.83. HRMS (ESI): m/z [M + H]⁺ calcd for C₃₂H₄₅O₈N₂P₂: 647.26457; found: 647.26495.(2R,2′R,3S,3′S)-N,N′-((1S,2S)-cyclohexane-1,2-diyl)bis(3-(tert-butyl)-4-methoxy-2H-benzo[d][1,3]oxaphosphole-2-carboxamide 3-oxide) (3b): Yield: 3.36 g (65%). ¹H NMR (400 MHz, CDCl₃): δ = 7.43 (t, J = 8.2 Hz, 2 H), 6.86 (br d, J = 6.0 Hz, 2 H), 6.62 (dd, J = 8.2, 3.0 Hz, 2 H), 6.50 (dd, J = 8.1, 4.4 Hz, 2 H), 5.22 (s, 2 H), 3.80 (s, 6 H), 3.73 (br s, 2 H), 2.12 (br d, J = 6.6 Hz, 2 H), 1.69 (br s, 2 H), 1.31–1.26 (overlapping d, J = 17.0 Hz, and m, 22 H). ¹³C NMR (100 MHz, CDCl₃): δ = 165.7 (d, J = 2.0 Hz), 165.3 (d, J = 15.3 Hz), 161.3 (d, J = 2.1 Hz), 136.8, 106.4 (d, J = 5.4 Hz), 103.8 (d, J = 5.8 Hz), 101.6 (d, J = 91.6 Hz), 74.6 (d, J = 48.3 Hz), 55.6, 53.5, 34.3 (d, J = 74.0 Hz), 32.2, 24.6, 24.5. ³¹P NMR (162 MHz, CDCl₃): δ = 62.36. HRMS (ESI): m/z [M + H]⁺ calcd for C₃₂H₄₅O₈N₂P₂: 647.26457; found: 647.26433.(2R,2′R,3S,3′S)-N,N′-(1,2-phenylene)bis(3-(tert-butyl)-4-methoxy-2H-benzo[d][1,3]oxaphosphole-2-carboxamide 3-oxide) (3c): Yield: 3.07 g (60%); ¹H NMR (400 MHz, CDCl₃): δ = 8.65 (s, 2 H), 7.54 (m, 2 H), 7.44 (t, J = 8.2 Hz, 2 H), 7.16 (m, 2 H), 6.68 (dd, J = 8.3, 2.8 Hz, 2 H), 6.54 (dd, J = 8.2, 4.4 Hz, 2 H), 5.33 (s, 2 H), 3.86 (s, 6 H), 1.34 (d, J = 17.1 Hz, 18 H); ¹³C NMR (100 MHz, CDCl₃): δ = 165.2 (d, J = 14.9 Hz), 164.5 (d, J = 2.6 Hz), 161.3 (d,J = 2.2 Hz), 137.0, 129.9, 126.7, 126.2, 106.5 (d, J = 5.4 Hz), 104.1 (d, J = 5.8 Hz), 102.0 (d, J = 91.6 Hz), 75.5 (d, J = 47.5 Hz), 55.7, 34.4 (d, J = 73.8 Hz), 24.7. ³¹P NMR (202 MHz, CDCl₃): δ = 63.9. HRMS (ESI): m/z [M + H]⁺ calcd for C₃₂H₃₉O₈N₂P₂: 641.21762; found: 641.21767.(2R,2′R,3S,3′S)-N,N′-((1R,2R)-1,2-dicyclohexylethane-1,2-diyl)bis(3-(tert-butyl)-4-methoxy-2H-benzo[d][1,3]oxaphosphole-2-carboxamide 3-oxide) (3d): Yield: 3.03 g (50%); ¹H NMR (400 MHz, CDCl₃): δ = 7.45 (t, J = 8.2 Hz, 2 H), 6.72–6.68 (overlapping s and dd, J = 8.2, 3.0 Hz, 4 H), 6.54 (dd, J = 8.1, 4.3 Hz, 2 H), 4.92 (d, J = 0.48 Hz, 2 H), 4.06–4.00 (m, 6 H), 3.88 (s, 6 H), 1.74–1.67 (m, 9 H), 1.54–1.34 (overlapping d, J = 17.0 Hz, and m, 24 H), 1.22–1.02 (m, 10 H), 0.9–0.81 (m, 2 H). ¹³C NMR (100 MHz, CDCl₃): δ = 165.1 (d, J = 2.3 Hz), 164.4 (d, J = 13.9 Hz), 161.1 (d, J = 2.1 Hz), 136.7, 106.5 (d, J = 5.2 Hz), 104.1 (d, J = 5.7 Hz), 103.1 (d, J = 90.5 Hz), 75.6 (d, J = 48.9 Hz), 55.6, 54.7, 38.9, 34.1 (d, J = 74.4 Hz), 30.5, 27.3, 26.2, 26.16, 26.11, 25.2. ³¹P NMR (162 MHz, CDCl₃): δ = 61.64. HRMS (ESI): m/z [M + H]⁺ calcd for C₄₀H₅₉O₈N₂P₂: 757.37412; found: 757.37417.(2R,2′R,3S,3′S)-N,N′-((1R,2R)-1,2-diphenylethane-1,2-diyl)bis(3-(tert-butyl)-4-methoxy-2H-benzo[d][1,3]oxaphosphole-2-carboxamide 3-oxide) (3e): Yield: 2.98 g (50%); ¹H NMR (500 MHz, CDCl₃): δ = 7.52 (br d, J = 2.8 Hz, 2 H), 7.43 (t, J = 8.2 Hz, 2 H), 7.11–7.06 (m, 10 H), 6.70 (dd, J = 8.3, 2.5 Hz, 2 H), 6.50 (dd, J = 8.1, 4.3 Hz, 2 H), 5.40–5.38 (m, 2 H), 5.00 (s, 2 H), 3.85 (s, 6 H), 1.35 (d, J = 16.9 Hz, 18 H). ¹³C NMR (100 MHz, CDCl₃): δ = 165.5 (d, J = 2.4 Hz), 164.5 (d, J = 14.1 Hz), 161.1 (d, J = 2.3 Hz), 137.7, 136.8, 128.5, 127.74, 127.69, 106.5 (d, J = 5.3 Hz), 104.0 (d, J = 5.8 Hz), 102.7 (d, J = 91.1 Hz), 75.3 (d, J = 48.8 Hz), 59.1, 55.6, 34.1 (d, J = 74.5 Hz), 25.1 (d, J = 0.8 Hz). ³¹P NMR (202 MHz, CDCl₃): δ = 62.13. HRMS (ESI): m/z [M + H]⁺ calcd for C₄₀H₄₇O₈N₂P₂: 745.28022; found: 745.28012.General procedure for enone reduction: To a stirring solution of 1a (60 mg, 0.27 mmol) and catalyst 3a (0.027 mmol, 10 mol%) in acetonitrile (2 mL) at 0 °C was added HSiCl₃ (1.35 mmol, 5 equiv) dropwise, and the mixture was stirred at 0 °C for 20 h. The reaction was then quenched with a solution of 5N aqueous NaOH (2 mL), and the mixture was warmed to room temperature then diluted with EtOAc and water. The phases were separated, and the aqueous phase was further extracted once with EtOAc. The combined organic layers were washed with water followed by brine, dried with Na₂SO₄ and concentrated. The product was purified on silica with a mixture of hexanes/EtOAc (10:1) to obtain a colorless oil after drying.(S)-1,3-Diphenylbutan-1-one (2a): Yield: 90%; 89.2:10.8 er; SFC (ES Industries CCA column 4.6 × 100 mm, 3 μm: 35 °C, A: CO₂, B: isopropanol; gradient: 1% B to 3% B in 3 min, to 50% B in 5 min; 3 mL/min, λ = 220 nm): t_R = 2.50 (major), 2.80 (minor) min. NMR data match those reported in the literature.^{17 1}H NMR (500 MHz, CDCl₃): δ = 7.96 (d, J = 7.9 Hz, 2 H), 7.57 (t, J = 7.3 Hz, 1 H), 7.47 (t, J = 7.6 Hz, 2 H), 7.35–7.21 (m, 4 H), 7.35–7.28 (m, 2 H), 7.23 (t, J = 6.8 Hz, 1 H), 3.54 (sextet, J = 6.9 Hz, 1 H), 3.33 (dd, J = 16.5, 5.7 Hz, 1 H), 3.22 (dd, J = 16.5, 8.3 Hz, 1 H), 1.37 (d, J= 6.9 Hz, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 199.1, 146.6, 137.2, 133.0, 128.6, 128.5, 128.1, 126.9, 126.3, 47.0, 35.6, 21.9.(S)-1-Phenyl-3-(4-(trifluoromethyl)phenyl)butan-1-one (2b): Yield: 92%; 89.4:10.6 er; SFC (ES Industries CCA column 4.6 × 100 mm, 3 μm: 35 °C, A: CO₂, B: isopropanol; gradient: 1% B to 3% B in 3 min, to 50% B in 5 min; 3 mL/min, λ = 220 nm): t_R = 1.69 (major), 1.91 (minor) min. NMR data match those reported in the literature.^{18 1}H NMR (400 MHz, CDCl₃): δ = 7.97–7.92 (m, 2 H), 7.60–7.56 (m, 3 H), 7.50–7.45 (m, 2 H), 7.41 (d, J = 8.3 Hz, 2 H), 3.69 (sextet, J = 6.9 Hz, 1 H), 3.35 (dd, J = 16.8, 6.4 Hz), 3.25 (dd, J = 16.9, 7.5 Hz, 1 H), 1.39 (d, J = 7.0 Hz, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 198.4, 150.6, 137.0, 133.2, 128.6, 128.0, 127.3, 125.5 (q, J = 3.8 Hz), 46.5, 35.3, 21.9.(S)-3-(4-Chlorophenyl)-1-phenylbutan-1-one (2c): Yield: 94%; 90.2:9.8 er; SFC (ES Industries CCA column 4.6 × 100 mm, 3 μm: 35 °C, A: CO₂, B: methanol; gradient: 1% B to 3% B in 3 min, to 50% B in 5 min; 3 mL/min, λ = 220 nm): t_R = 2.93 (major), 3.51 (minor) min. NMR data match those reported in the literature.^{18 1}H NMR (400 MHz, CDCl₃): δ = 7.95–7.92 (m, 2 H), 7.60–7.56 (m, 1 H), 7.50–7.45 (m, 2 H), 7.30–7.27 (m, 2 H), 7.25–7.21 (m, 2 H), 3.52 (sextet, J = 6.9 Hz, 1 H), 3.29 (dd, J = 16.7, 6.3 Hz), 3.2 (dd, J = 16.7, 7.7 Hz, 1 H), 1.35 (d, J= 7.0 Hz, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 198.7, 145.0, 137.1, 133.1, 131.9, 128.6, 128.3, 128.0, 46.8, 35.0, 22.0.(S)-3-(2-Methoxyphenyl)-1-phenylbutan-1-one (2d): Yield: 89%; 88.1:11.9 er; SFC (Lux Cel 1 column 4.6 × 100 mm, 3 μm: 35 °C, A: CO₂, B: methanol; gradient: 1% B to 3% B in 3 min, to 50% B in 5 min; 3 mL/min, λ = 220 nm): t_R = 3.94 (major), 4.27 (minor) min. NMR data match those reported in the literature.^{19 1}H NMR (500 MHz, CDCl₃): δ = 7.90 (d, J = 7.8 Hz, 2 H), 7.45 (t, J = 7.3 Hz, 1 H), 7.36 (t, J = 7.6 Hz, 2 H), 7.15 (d, J = 7.3 Hz, 1 H), 7.11 (t, J = 7.7 Hz, 1 H), 6.85 (t, J = 7.4 Hz, 1 H), 6.77 (d, J = 8.1 Hz, 1 H), 3.78–3.73 (m, 1 H), 3.73 (s, 3 H), 3.27 (dd, J = 15.8, 4.8 Hz, 1 H), 2.97 (dd, J = 15.7, 9.2 Hz, 1 H), 1.23 (d, J = 7.0 Hz, 3 H). ¹³C NMR (125 MHz, CDCl₃): δ = 199.7, 156.9, 137.3, 134.5, 132.8, 128.5, 128.2, 127.2, 126.9, 120.7, 110.6, 55.3, 46.0, 29.6, 19.7.
13 (S)-isomer was assigned by comparison to the reported data in ref. 4b.
14 Frisch M. J., Trucks G. W., Schlegel H. B., Scuseria G. E., Robb M. A., Cheeseman J. R., Scalmani G., Barone V., Petersson G. A., Nakatsuji H., Li X., Caricato M., Marenich A. V., Bloino J., Janesko B. G., Gomperts R., Mennucci B., Hratchian H. P., Ortiz J. V. Izmaylov, A. F., Sonnenberg J. L., Williams-Young D., Ding F., Lipparini F., Egidi F., Goings J., Peng B., Petrone A., Henderson T., Ranasinghe D., Zakrzewski V. G., Gao J., Rega N., Zheng G., Liang W., Hada M., Ehara M., Toyota K., Fukuda R., Hasegawa J., Ishida M., Nakajima T., Honda Y., Kitao O., Nakai H., Vreven T., Throssell K., Montgomery J. A. Jr., Peralta J. E., Ogliaro F., Bearpark M. J., Heyd J. J., Brothers E. N., Kudin K. N., Staroverov V. N., Keith T. A., Kobayashi R., Normand J., Raghavachari K., Rendell A. P., Burant J. C., Iyengar S. S., Tomasi J., Cossi M., Millam J. M., Klene M., Adamo C., Cammi R., Ochterski J. W., Martin R. L., Morokuma K., Farkas O., Foresman J. B., Fox D. J.; Gaussian 16, Revision B.01; Gaussian, Inc., Wallingford CT, 2016

15a Becke AD. J. Chem. Phys. 1993; 98: 5648
15b Lee C, Yang W, Parr RG. Phys. Rev. B: Condens. Matter Mater. Phys. 1988; 37: 785

16 Sugiura M, Ashikari Y, Takahashi Y, Yamaguchi K, Kotani S, Nakajima M. J. Org. Chem. 2019; 84: 11458
17 Kanazawa Y, Tshchiya Y, Kobayashi K, Shiomi T, Itoh J.-I, Kikuchi M, Yamamoto Y, Nishiyama H. Chem. Eur. J. 2006; 12: 63
18 Miaskiewicz S, Reed JH, Donets PA, Oliveira CC, Cramer N. Angew. Chem. Int. Ed. 2018; 57: 4039
19 Yamamoto Y, Kurihara K, Takahashi Y, Miyaura N. Molecules 2013; 18: 14

Zusatzmaterial

Supporting Information